Breast Neoplasms: all 12,820 studies

Page 86 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.

• Hypofractionated vs Standard Radiotherapy in Breast Cancer With an Indication for Regional Lymph Node Irradiation About Lymphedema OccurrenceActive, not recruitingNCT03127995Not applicable
• Metastatic Breast Cancer Treatment PlanningWithdrawnNCT03127332Not applicable
• High Intensity Focused Ultrasound Guided by MRI as Thermic Destruction in Primitive Small Size Breast CancerWithdrawnNCT03126487Not applicable
• Combined Training Intervention for Women Who Underwent Primary Treatment for Breast CancerCompletedNCT03124095Not applicable
• Efficacy and Safety of Neoadjuvant DC-T in Breast Cancer PatientsStatus unknownNCT03123770Phase 4
• Imipramine on ER+ve and Triple Negative Breast CancerCompletedNCT03122444Early Phase 1
• Study to Evaluate the Feasibility of 13-C Pyruvate Imaging in Breast Cancer Patients Receiving Neoadjuvant ChemotherapyWithdrawnNCT03121989Phase 1
• Outcome of 15 Versus 5 Fractions in Adjuvant Breast Radiotherapy in Women Over 65 YearsActive, not recruitingNCT03121248Not applicable
• PECS-2 for Breast SurgeryCompletedNCT03117894Not applicable
• Impact of Pre-Operative Web-based Breast Cancer Information on the Quality of Patient Decision-MakingCompletedNCT03116035Not applicable
• Physical Activity and First Degree Female Relatives of Breast Cancer PatientsCompletedNCT03115658Not applicable
• Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing SurgeryCompletedNCT03113825Phase 2
• Autologous Antigen-activated Dendritic Cells in the Treatment of Patients With Breast CancerStatus unknownNCT03113019Early Phase 1
• Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their PartnersCompletedNCT03112668Not applicable
• HOrmone Therapy Immediately After Histological Diagnosis of Breast CancerStatus unknownNCT03111615Phase 4
• Cancer/Testis Antigen Immunotherapy Phase I Study With 740-CTA Vaccinia VirusWithdrawnNCT03110445Phase 1
• A Pilot Study to Evaluate the Impact of Dexmedetomidine on Breast Cancer Recurrence After SurgeryCompletedNCT03109990Not applicable
• Axillary Reverse Mapping (ARM) TechniqueStatus unknownNCT03109522Not applicable
• Pharmacokinetic Study of SPARC1613 and reference1613 in Subjects With Locally Recurrent or Metastatic Breast CancerCompletedNCT03109249Phase 1
• Effects of Dexmedetomidine on Breast Cancer Cell Function in VitroCompletedNCT03108937Not applicable
• Involvement of the Inositol-trisphosphate Receptor in Invasive or Migratory-type Breast CancersCompletedNCT03107234
• The Oncological Safety and Cosmetic Outcome of Areola Sparing Mastectomy : a Single Arm, Prospective, Cohort StudyStatus unknownNCT03105570Not applicable
• Impact of Decision Aids on Breast Cancer Surgery Choice: A Randomized Controlled TrialCompletedNCT03105076Not applicable
• Effect of Early Removal of Wound Drains After Mastectomy or Lymph Node DissectionCompletedNCT03104153Not applicable
• Aerobic and Strength Training Exercise in Improving Fitness and Arm Health During and After Radiation Therapy in Patients With Stage II-III Breast CancerCompletedNCT03102866Not applicable
• Registry Trial to Evaluate the Clinical Utilization of Targeted Axillary Dissection (TAD)CompletedNCT03102307
• Radiotherapy After Mastectomy for Breast Cancer Patients at Increased Risk of Local RecurrenceStatus unknownNCT03101683Not applicable
• Online Mindfulness for Women Treated for Breast Cancer and Men Treated for Prostate CancerCompletedNCT03100981Not applicable
• An Observational Study Evaluating the Productivity and Health-Related Quality of Life of People With HER2 Positive Breast CancerCompletedNCT03099200
• A Phase I Trial of LY3143921 Hydrate in Solid TumoursCompletedNCT03096054Phase 1
• Phase 3 Study Randomized Evaluating the Efficacy of Auriculotherapy in Patients With Musculoskeletal Pain by Aromatase InhibitorsCompletedNCT03096041Not applicable
• Clinic Study of 18F-Al-NOTA-MATBBN in Cancer DiagnosticsStatus unknownNCT03094897Early Phase 1
• AGE Levels in ER+ Metastatic Breast Cancer Patients Receiving Endocrine TherapyTerminatedNCT03092635Phase 1
• Exercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast CancerWithdrawnNCT03091842Not applicable
• Acupressure for Cancer-Related FatigueStatus unknownNCT03091647Not applicable
• Efficacy of Cardio-Oncology Rehabilitation Exercise for Women With Breast Cancer and Treatment Related CardiotoxicityTerminatedNCT03089502Not applicable
• Phase 1, First-in-Human Study of RAD140 in Postmenopausal Women With Breast CancerCompletedNCT03088527Phase 1
• Bridging the Gap: Incorporating Exercise Evidence Into Clinical Practice in Breast Cancer Care in OntarioCompletedNCT03087461Not applicable
• High-dose Chemotherapy With Hematopoietic Stem-cell Rescue for High-risk Breast Cancer: Long-term Follow-upCompletedNCT03087409
• Prospective, Multicenter, Observational Study of Apatinib Single or Combined Capecitabine for Treatment of Patients With Metastatic Her-2 Negative Breast CancerStatus unknownNCT03086785Phase 2
• A Randomized Controlled Trial of HER-2 Positive Breast Cancer Patients Treated With Lapatinib vs HerceptinStatus unknownNCT03085368Phase 2/3
• Efficacy and Safety of Trastuzumab Emtansine in Chinese Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced or Metastatic Breast CancerCompletedNCT03084939Phase 3
• Selective Axillary Lymph Node Dissection Vs Complete Axillary Dissection: A Randomised Clinical Trial to Assess the Prevention of Lymphedema in Breast Cancer TreatmentCompletedNCT03083314Not applicable
• Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Breast CancerActive, not recruitingNCT03083288Phase 1
• Molecular Breast Imaging in Screening Breast CancerCompletedNCT03082456Not applicable
• Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- Intermediate Risk Early Breast CancerWithdrawnNCT03081234Phase 3
• Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer. (PHOEBE)Status unknownNCT03080805Phase 3
• Assessment of Genomic Test Impact on Shared Decision of Adjuvant Chemotherapy in ER-positive, Her2-negative Early Breast CancerWithdrawnNCT03080428Not applicable
• Evaluation of a Three Dimensional Functional Metabolic Imaging and Risk Assessment System in Classifying Women for Likelihood of Breast CancerStatus unknownNCT03080155Not applicable
• Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Chinese Breast Cancer PatientsCompletedNCT03079219Phase 3
• PAlbociclib and Circulating Tumor DNA for ESR1 Mutation DetectionCompletedNCT03079011Phase 3
• International Breast Cancer Biomarker,Standard of Care and Real World Outcomes StudyCompletedNCT03078036
• Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast CancerSuspendedNCT03077841Phase 2/3
• Toxicity and Outcome of Whole Breast Hypofractionated Radiotherapy: a Single Institution ExperienceActive, not recruitingNCT03077191
• A Study of Fluzoparib Given in Combination With Apatinib in Ovarian or Breast Cancer PatientsCompletedNCT03075462Phase 1
• "Curcumin" in Combination With Chemotherapy in Advanced Breast CancerCompletedNCT03072992Phase 2
• Development of Distress Management Algorithms Using Mobile Device Based Health Logs in Breast Cancer SurvivorsCompletedNCT03072966Not applicable
• Impact of Radiotherapy on Patients Undergoing DIEP Flap Breast ReconstructionStatus unknownNCT03072316
• Metronomic PLD in Patients With Primary Endocrine Resistant ABCStatus unknownNCT03071926Phase 2
• iNPWT in Immediate Breast ReconstructionStatus unknownNCT03069885Not applicable
• Study of Web-based Decision Aids for Increasing Breast Cancer Chemoprevention in the Primary Care SettingCompletedNCT03069742Not applicable
• Intraoperative Indocyanine Green Laser Angiography; Postoperative Outcomes for Autologous Tissue FlapsCompletedNCT03069261
• Test - Retest Reproducibility of 18F Fluoroestradiol (FES) PETWithdrawnNCT03065712Phase 2
• Neoadjuvant Biomarker ResearcH Study of Palbociclib Combined With Endocrine Therapy in Estrogen Receptor Positive/HER2 Negative Breast CAncer (NeoRHEA)CompletedNCT03065621Phase 2
• Observational STudy to Evaluate the EFfectiveness of OnLife® in Improving CIPN in Patients With Colon or Breast Cancer After End of Adj. TherapyCompletedNCT03065478
• Study of BCD-115 in Women With ER(+) HER2(-) Local Advanced and Metastatic Breast CancerCompletedNCT03065010Phase 1
• The Effects of Anthracycline-based Chemotherapy on Peripheral Vascular FunctionCompletedNCT03062878
• Open-label Study of Safety, Tolerability and Pharmacokinetics of Multiple Doses of BI-CON-02 in Patients With HER2-positive Metastatic Breast Cancer, Previously Treated With TrastuzumabTerminatedNCT03062007Phase 1
• Physical Training on Patients With Breast CancerCompletedNCT03061773Not applicable
• Place of Comprehensive Geriatric Assessment in Patients ≥ 75 Years Care, With Breast Cancer, After Screening With FOG (Oncology Geriatric Filter)Active, not recruitingNCT03059875Not applicable
• Assessing the Response Rate of Neo-adjuvant Paclitaxel (Taxol) in Nigerian Women With Breast CancerWithdrawnNCT03058939Phase 2
• Imaging of in Vivo Sigma-2 Receptor Expression With 18F-ISO-1 Positron Emission Tomography in Metastatic Breast CancerTerminatedNCT03057743
• Bicalutamide in Treatment of Androgen Receptor (AR) Positive Metastatic Triple Negative Breast CancerTerminatedNCT03055312Phase 3
• Study of Doxorubicin in Patients With Metastatic Breast Cancer/Advanced Ovarian CancerCompletedNCT03055143Phase 1
• Smart Phone Application in Increasing Physical Activity in Breast Cancer SurvivorsTerminatedNCT03054025Not applicable
• A Study of RC48-ADC in Subjects With Advanced Breast CancerCompletedNCT03052634Phase 1/2
• Physical Evaluation and Quality of Life in the Practice of Fencing in Breast Cancer SupportCompletedNCT03051828
• Kinesio Taping Versus Compression Garments for Breast Cancer-Related LymphedemaCompletedNCT03051776Not applicable
• Comparison of Techniques for Breast Cancer-Related Lymphedema.CompletedNCT03051750Not applicable
• Functional Magnetic Resonance Imaging in Assessing Affect Reactivity and Regulation in Patients With Stage 0-III Breast CancerCompletedNCT03050463
• Efficacy and Safety of Dexmedetomidine Added to Modified Pectoral's Block in Breast Cancer PatientsStatus unknownNCT03046238Phase 3
• Effect of Information About the Benefits and Harms of Mammography on Women's Decision MakingCompletedNCT03046004Not applicable
• Objective Assessment of Physical Activity During Chemotherapy for Breast CancerCompletedNCT03045575
• Mirvetuximab Soravtansine (IMG853) in Folate Receptor Alpha-expressing TNBCWithdrawnNCT03045393Phase 1
• A Whole-food, Plant-Based Nutrition Intervention in Women With Metastatic Breast CancerCompletedNCT03045289Not applicable
• Tracking Physical Activity Throughout Chemotherapy for Breast CancerCompletedNCT03041545
• Opting for Breast Reconstruction After Mastectomy or Not: Search for Influencing FactorsStatus unknownNCT03039348
• Cardiac Rehabilitation Program in Improving Cardiorespiratory Fitness in Stage 0-III Breast Cancer SurvivorsCompletedNCT03039140Not applicable
• Immunostimulating Interstitial Laser Thermotherapy in Breast CancerTerminatedNCT03039127Not applicable
• Magseed Magnetic Marker in Locating Axillary Lymph Nodes in Patients With Breast Cancer Undergoing SurgeryCompletedNCT03038152Phase 4
• Fluciclovine (18F) Imaging of Breast CancerCompletedNCT03036943Not applicable
• Sienna and Sentimag in Sentinel Lymph Node BiopsyStatus unknownNCT03036475Not applicable
• The IMPETUS Cancer Trial. A Technology Delivered Physical Activity Intervention in CancerStatus unknownNCT03036436Not applicable
• Ultrasound Imaging Technique in Detecting Breast Microcalcifications in Patients Undergoing Biopsy for a Breast AbnormalityCompletedNCT03031561Not applicable
• Establishing Technique for PECS2 Catheter InsertionCompletedNCT03030677Not applicable
• Simulated-altitude to Optimize Aerobic Exercise Among Breast Cancer Survivors With Limited MobilityCompletedNCT03029182Not applicable
• Impact of Exercise on Mitigating the Cardio-toxic Effects of Adriamycin Among Women Newly Diagnosed With Breast Cancer.CompletedNCT03027063Not applicable
• Effect of a Mentor-based, Supportive-expressive Program on Survival in Metastatic Breast CancerStatus unknownNCT03026374Not applicable
• Outcomes Of The Spanish Cohort Of Early Access To Pertuzumab And Trastuzumab EmtansineCompletedNCT03025711
• Mindfulness Meditation or Survivorship Education in Improving Behavioral Symptoms in Younger Stage 0-III Breast Cancer Survivors (Pathways to Wellness)Status unknownNCT03025139Not applicable

← Breast Neoplasms overview